Glenmede Investment Management’s Heron Therapeutics HRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$145K Buy
+70,250
New +$145K ﹤0.01% 1273